XL-protein GmbH
XL-protein is a German biotech company commercializing its ground-breaking PASylation® technology, which enables the design of biopharmaceuticals with extended plasma half-life as well as prolonged residence time in the eye. Based on a strong proprietary technology position, XL-protein focuses at the preclinical as well as clinical development of PASylated proteins in diverse disease areas. XL-protein is engaged in numerous partnerships with international pharmaceutical and biotech companies at various levels.
Lise-Meitner-Str. 30
Deutschland-85354 Freising
Telefon: +49 (0) 8161 53730-90
Fax: +49 (0) 8161 53730-99
http://www.xl-protein.com
info@
xl-protein.com